WigginsJ, StricklandB, Turner-WarwickM. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med, 1990; 84(5):365–369.
HiwatariN, ShimuraS, TakishimaT. Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration, 1993; 60(6):354–358.
4.
CottinV, NunesH, BrilletPY, DelavalP, DevouassouxG, Tillie-LeblondIet al; Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J, 2005; 26(4):586–593.
5.
LimTK. Respiratory failure from combined emphysema and pulmonary fibrosis. Singapore Med J, 1993; 34(2):169–171.
6.
JankowichMD, PolskyM, KleinM, RoundsS. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration, 2008; 75(4):411–417.
7.
GrubsteinA, BendayanD, SchactmanI, CohenM, ShitritD, KramerMR. Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med, 2005; 99(8):948–954.
8.
BarnhartS, HudsonLD, MasonSE, PiersonDJ, RosenstockL. Total lung capacity. An insensitive measure of impairment in patients with asbestosis and chronic obstructive pulmonary disease?. Chest, 1988; 93(2):299–302.
9.
LundbladLK, Thompson-FigueroaJ, LeclairT, SullivanMJ, PoynterME, IrvingCG, BatesJH. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med, 2005; 171(12):1363–1370.
10.
DaniilZ, KoutsokeraA, GourgoulianisK. Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds. Eur Respir J, 2006; 27(2):434..
11.
HunninghakeGW, ZimmermanMB, SchwartzDA, KingTEJr, LynchJ, HegeleR, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2001; 164(2):193–196.
12.
RaghuG, CollardHR, EganJJ, MartinezFJ, BehrJ, BrownKKet al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med, 2011; 183(6):788–824.
13.
JankowichMD, RoundsS. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung, 2010; 188(5):365–373.
14.
AkagiT, MatsumotoT, HaradaT, TanakaM, KurakiT, FujitaM, WatanabeK. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med, 2009; 103(8):1209–1215.
15.
KitaguchiY, FujimotoK, HanaokaM, KawakamiS, HondaT, KuboK. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology, 2010; 15(2):265–271.
16.
MejíaM, CarrilloG, Rojas-SerranoJ, EstradaA, SuárezT, AlonsoD, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest, 2009; 136(1):10–15.
17.
SchmidtSL, NambiarAM, TayobN, SundaramB, HanMK, GrossBH, et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J, 2011; 38(1):176–183.
18.
CottinV, Le PavecJ, PrévotG, MalH, HumbertM, SiomnneauGet al; Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J, 2010; 35(1):105–111.
19.
UsuiK, TanaiC, TanakaY, NodaH, IshiharaT. The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology, 2011; 16(2):326–331.
